M. Macleod et al., RENAL-ARTERY STENOSIS MANAGED BY PALMAZ STENT INSERTION - TECHNICAL AND CLINICAL OUTCOME, Journal of hypertension, 13(12), 1995, pp. 1791-1795
Objective: To assess the technical and clinical outcome of Palmaz rena
l artery stent insertion in patients with renal artery stenosis. Desig
n: Twenty-nine patients with radiological evidence of renal artery ste
nosis and hypertension (16 patients, mean+/-SD diastolic blood pressur
e 100.5+/-8.16 mmHg) and/or renal impairment (17 patients, mean+/-SD s
erum creatinine 376+/-169 mu mol/l) were referred for radiological int
ervention. Of these, 22 had ostial atheromatous lesions, six had ather
omatous non-ostial lesions and one patient had fibromuscular dysplasia
. Palmaz stent insertion was performed where either previous or concom
itant percutaneous transluminal renal angioplasty (PTRA) had been unsu
ccessful. Technical success was defined primarily as <30% residual ste
nosis. A prospective radiological and clinical follow-up was performed
and the results compared with the outcome following PTRA alone in a s
imilar group of patients from our centre. Results: Immediate technical
success was achieved in all 29 patients. Follow-up angiography in 24
patients after a mean of 7 months showed restenosis in four patients.
The hypertension was not 'cured' in any patient; a blood pressure fall
was observed in seven patients (44%) and no change in the remaining n
ine subjects (56%). Renal function improved in four patients (24%), tw
o of whom had angiotensin converting enzyme inhibitor-exacerbated rena
l impairment. This compares with an immediate technical success of 81%
for PTRA alone, with cure in 50% and improvement in 32% of patients w
ith hypertension and improvement in renal function in 64.7% of patient
s with renal impairment. Conclusions: Palmaz renal artery stent insert
ion has a higher technical success rate than PTRA, but the clinical im
provement is disappointing in our patient population.